Inicio › Tumores cerebrales › Texas › Houston
Ensayos clínicos de Tumores cerebrales en Houston, TX
37 estudios para Tumores cerebrales buscan participantes en centros de Houston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
ReclutandoFase 2
- UT MD Anderson Cancer Center, Houston
A Phase I Clinical Study of YN003 in the Treatment of Glioma
ReclutandoFase 1
- The University of Texas MD Anderson Cancer Center, Houston
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Reclutando
- M D Anderson Cancer Center, Houston
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
ReclutandoEstudio observacional
- M D Anderson Cancer Center, Houston
Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
Reclutando
- MD Anderson Cancer Center, Houston
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
ReclutandoFase 2
- University of Texas MD Anderson Cancer Center, Houston
Mapping of Human Cognition
Reclutando
- The University of Texas Health Science Center at Houston, Houston
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
ReclutandoFase 2
- UT MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ReclutandoFase 1/2
- MD Anderson Cancer Center, Houston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
ReclutandoFase 1/2
- MD Anderson Cancer Center, Houston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
ReclutandoFase 1/2
- University of Texas MD Anderson Cancer Center, Houston
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
ReclutandoFase 2
- M D Anderson Cancer Center, Houston
EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
ReclutandoFase 2
- The University of Texas MD Anderson Cancer Center, Houston
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
ReclutandoFase 1
- Baylor St. Luke's Medical Center, Houston
Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
ReclutandoFase 2
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
ReclutandoFase 2
- M D Anderson Cancer Center, Houston
OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy
ReclutandoFase 1
- MD Anderson Cancer Center, Houston
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
ReclutandoFase 2
- Texas Children's Hospital, Houston
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
ReclutandoEstudio observacional
- M D Anderson Cancer Center, Houston
A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
ReclutandoEstudio observacional
- MD Anderson Cancer Center, Houston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ReclutandoFase 1
- MD Anderson Cancer Center - University of Texas, Houston
Targeted Pediatric High-Grade Glioma Therapy
ReclutandoEstudio observacional
- Texas Children's Hospital, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
ReclutandoFase 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
ReclutandoFase 2
- Texas Children's Hospital, Houston
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
ReclutandoFase 2
- MD Anderson Cancer Center, Houston
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
ReclutandoFase 1
- The University of Texas M.D. Anderson Cancer Center, Houston
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
ReclutandoFase 2
- Houston Methodist Neal Cancer Center, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
ReclutandoFase 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
ReclutandoFase 1
- Texas Children's Hospital, Houston
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
ReclutandoEstudio observacional
- Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
ReclutandoFase 2
- M D Anderson Cancer Center, Houston
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
ReclutandoFase 1
- M D Anderson Cancer Center, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
ReclutandoFase 2
- Texas Children's Hospital, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
ReclutandoEstudio observacional
- Md Anderson Cancer Center, Houston
Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
ReclutandoFase 2
- M D Anderson Cancer Center, Houston
Systematic Light Exposure in Pediatric Brain Tumor Survivors
Reclutando
- Texas Children's Hospital, Houston
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
ReclutandoFase 1/2
- MD Anderson, Houston
Más información sobre Tumores cerebrales en MedlinePlus
Ensayos de Tumores cerebrales en otras ciudades
- Boston, MA29 estudios
- New York City, NY25 estudios
- Washington, DC21 estudios
- Los Angeles, CA17 estudios
- Durham, NC15 estudios
- Miami, FL14 estudios
- Chicago, IL12 estudios
- Rochester, MN12 estudios
- St. Louis, MO12 estudios
- Cleveland, OH11 estudios
- Columbus, OH11 estudios
- Seattle, WA11 estudios
Otros estudios en Houston
- Cáncer de pulmón de células no pequeñas143 estudios
- Cáncer de seno126 estudios
- Cáncer (todos los tipos)124 estudios
- Cáncer del colon y del recto101 estudios
- Cáncer metastásico100 estudios
- Cáncer de ovario90 estudios
- Leucemia mielógena aguda88 estudios
- Cáncer de pulmón78 estudios
- Cáncer de próstata73 estudios
- Cáncer de endometrio69 estudios
- Melanoma61 estudios
- Cáncer de páncreas59 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.